[1] KABAT G C,ROHAN T E.Does excess iron play a role in breast carcinogenesis? an unresolved hypothesis[J]. Cancer Causes Control,2007,18(10):1047-1053. [2] SIDDIQUE A,KOWDLEY K V.Review article:the iron overload syndromes[J]. Aliment Pharmacol Ther,2012,35(8):876-893. [3] SHEFTEL A D,MASON A B,PONKA P.The long history of iron in the Universe and in health and disease[J]. Biochim Biophys Acta BBA Gen Subj,2012,1820(3):161-187. [4] MENA N P,URRUTIA P J,LOURIDO F,et al.Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders[J]. Mitochondrion,2015,21:92-105. [5] XU J Z,JIA Z H,KNUTSON M D,et al.Impaired iron status in aging research[J]. Int J Mol Sci,2012,13(2):2368-2386. [6] HUANG X,XU Y J,PARTRIDGE N C.Dancing with sex hormones,could iron contribute to the gender difference in osteoporosis?[J]. Bone,2013,55(2):458-460. [7] 王丽娟. 中国大城市与贫困农村居民铁营养状况综合评估[D]. 北京:中国疾病预防控制中心,2015. [8] 王瑞,葛红卫,郭瑾,等. 单采血小板献血者铁蛋白状况调查与分析[J]. 中国输血杂志,2021,34(1):8-12. [9] 郭瑾,施欣,王瑞,等. 北京地区全血献血者铁蛋白调查分析[J]. 中国输血杂志,2021,34(1):4-7. [10] FURUTA M,SHIMIZU T,MIZUNO S,et al.Clinical evaluation of repeat apheresis donors in Japan[J]. Vox Sang,1999,77(1):17-23. [11] Office of the Federal Register, National Archives and Records Administration. Requirements for Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use. [EB/OL]. (2015-05-22). https://www.govinfo.gov/app/details/FR-2015-05-22/2015-12228. [12] 国家卫生健康委员会. 献血浆者须知(2021年版)[EB/OL]. (2021-09-09).http://www.nhc.gov.cn/yzygj/s7658/202109/ca7e7e1972ec4e939c613aa67f7434e1.shtml. [13] 张美瑜,廖清奎. 铁在人体内的分布与作用[J]. 国外医学输血及血液学分册,1988(2):109-111. [14] ADAMS P C.Epidemiology and diagnostic testing for hemochromatosis and iron overload[J]. Int J Lab Hematol,2015,37(Suppl 1):25-30. [15] DEVER J B,MALLORY M A,MALLORY J E,et al.Phenotypic characteristics and diagnoses of patients referred to an iron overload clinic[J]. Dig Dis Sci,2010,55(3):803-807. [16] WHO. Serum ferritin concentrations for the assessment of iron status in individuals and populations: technical brief.[EB/OL]. (2020-12-14). https://www.who.int/publications/i/item/9789240008526 [17] 国家卫生健康委员会. 2019年国家血液安全报告[M]. 北京: 人民卫生出版社,2019. [18] BECHTLOFF S,TRAN-MY B,HAUBELT H,et al.A prospective trial on the safety of long-term intensive plasmapheresis in donors[J]. Vox Sang,2005,88(3):189-195. [19] JIAN J L,PELLE E,HUANG X.Iron and menopause:does increased iron affect the health of postmenopausal women?[J]. Antioxid Redox Signal,2009,11(12):2939-2943. [20] CHO G J,SHIN J H,YI K W,et al.Serum ferritin levels are associated with metabolic syndrome in postmenopausal women but not in premenopausal women[J]. Menopause,2011,18(10):1120-1124. [21] SUNG K C,KANG S M,CHO E J,et al.Ferritin is independently associated with the presence of coronary artery calcium in 12,033 men[J]. Arterioscler Thromb Vasc Biol,2012,32(10):2525-2530. [22] ZARJOU A,JENEY V,AROSIO P,et al.Ferritin ferroxidase activity:a potent inhibitor of osteogenesis[J]. J Bone Miner Res,2010,25(1):164-172. [23] 冯玉爽,徐又佳,马勇,等. 高龄女性骨质疏松性骨折与血清铁过载的关系[J]. 江苏医药,2011,37(8):896-898. [24] MAINOUS A G 3rd,GILL J M,EVERETT C J. Transferrin saturation,dietary iron intake,and risk of cancer[J]. Ann Fam Med,2005,3(2):131-137. [25] SILVA B,FAUSTINO P.An overview of molecular basis of iron metabolism regulation and the associated pathologies[J]. Biochim Biophys Acta BBA Mol Basis Dis,2015,1852(7):1347-1359. [26] LI H H,CONDON F,KESSLER D,et al.Evidence of relative iron deficiency in platelet- and plasma-pheresis donors correlates with donation frequency[J]. J Clin Apher,2016,31(6):551-558. [27] PASRICHA S R,TYE-DIN J,MUCKENTHALER M U,et al.Iron deficiency[J]. Lancet,2021,397(10270):233-248. [28] SCHMIDT A E,MACKERCHER J,YOUNGLING B,et al.Source plasma deferral trends:a 3-year analysis of 255 centers in the United States[J]. J Clin Apher,2022,37(1):31-39. [29] 熊恺轩,卢亮,邵超鹏,等. 育龄女性固定献血者铁缺乏与补铁方案的研究[J]. 中国输血杂志,2008,21(2):139-141. |